Title : Application of Anlotinib Combined With Neoadjuvant Chemotherapy in Primary EWS/PNET of Lung: A Case Report.

Pub. Date : 2022

PMID : 35530342






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Anlotinib is a new oral small molecular multi-targeted receptor tyrosine kinase (RTK) inhibitor. anlotinib ret proto-oncogene Homo sapiens
2 Anlotinib is a new oral small molecular multi-targeted receptor tyrosine kinase (RTK) inhibitor. anlotinib ret proto-oncogene Homo sapiens